Abbott Bets On China With New Nutritional Plant
This article was originally published in PharmAsia News
Executive Summary
Abbott Laboratories Inc. announced Aug. 16 it will build a $230 million nutritional manufacturing plant in Jiaxing, China, its largest investment to date in the country